MediciNova, Inc. ( MNOV) - Key Metrics
MNOV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.05 | -$109.44 | -$109.66 |
| 2026Q1 | $0 | -$0.05 | -$0.07 | -$0.07 |
| 2025Q4 | $0 | -$0.06 | -$0.04 | -$0.04 |
| 2025Q3 | $0 | -$0.06 | -$0.03 | -$0.03 |
| 2025Q2 | $0 | -$0.07 | -$0.05 | -$0.05 |
MNOV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -6.60 |
| 2026Q1 | 0% | -6.52 |
| 2025Q4 | 0% | -5.99 |
| 2025Q3 | 0% | -5.29 |
| 2025Q2 | 0% | -4.90 |
MNOV
Price: $1.40
52 week price:
Earnings Per Share: -0.21 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 32551
Ebitda: -3.3 millionMarket Capitalization: 87.6 million